伊萨夫可纳作为多种病原体诱导免疫功能低下宿主严重肺炎的最佳治疗选择:一系列病例报告
Xinyin Wang1, Yanjing You1, Shuyang Chen2
1Department of Pulmonary and Critical Care Medicine, Fuzong Clinical Medical College of Fujian Medical University, Dongfang Hospital of Xiamen University, School of Medicine, Xiamen University, 900th Hospital of PLA Joint Logistic Support Force, Fuzhou, Fujian, China.
伊萨夫可纳有效地治疗了侵袭性阿斯伯吉洛症的免疫受损患者的严重肺炎. 这种抗真菌剂表现出良好的疗效和安全性,为复杂感染提供了有价值的选择.
科学领域:
- 医学真菌学 医学真菌学
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
背景情况:
- 免疫受损宿主 (ICHs) 面临来自多种病原体的严重肺炎挑战.
- 下一代三抗真菌伊萨夫康纳 (ISA) 显示出真菌感染的潜力.
- 在ISA上,关于ICH复杂感染的临床数据有限.
研究的目的:
- 评估Isavuconazole (ISA) 在免疫功能低下宿主 (ICHs) 中治疗由多种病原体引起的严重肺炎的疗效和安全性,包括侵入性阿斯伯吉洛症 (IA).
主要方法:
- 分析了三名免疫功能低下患者 (ICH) 患有严重肺炎和侵入性阿斯伯吉洛症 (IA) 的病例系列.
- 患者接受了基于伊萨夫康纳 (ISA) 的个性化抗菌疗法.
- 监测了临床结果,包括症状缓解,病变吸收和不良事件.
主要成果:
- 这三名患者在基于ISA的治疗后都显示出症状缓解.
- 肺病变显著吸收,没有显著的肝毒性副作用.
- 治疗后没有观察到感染的复发.
结论:
- 伊萨夫可纳 (ISA) 在治疗免疫功能受损宿主 (ICHs) 侵袭性阿斯伯吉洛症 (IA) 中表现出强大的疗效和最小的药物不良反应 (ADR).
- 在ICH患者的严重肺炎中,ISA是一种有价值的治疗选择,特别是在共感染的情况下.
- 考虑免疫抑制和有效的抗微生物药物的平衡,逐步的治疗策略对于管理这些复杂的病例至关重要.
更多相关视频
06:49Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
09:57Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
相关概念视频
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pneumonia II: Pathophysiology
